BMA Biomedicals

BMA Biomedicals specialize in developing and producing innovative immunoassays, as well as generating monoclonal and polyclonal antibodies used in immunological techniques for in vitro research purposes.

In the past, we have adapted the production of our monoclonal antibodies to culture media free of fetal calf serum. This not only represents an important ethical contribution to sustainability and animal welfare, but the use of FCS-free culture media also offers scientific advantages, such as increased experimental reproducibility, elimination of the risk of contamination by animal viruses and bacteria, and thus more consistent performance.

All products are entirely manufactured in Switzerland, ensuring the highest standards of quality, consistency, and regulatory compliance.